Retatrutide appears to be a new medication in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimately leads to significant weight loss. While furthe